Chordate Medical Holding AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMH.ST research report →
Companywww.chordate.com
Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. The company was founded in 2005 and is based in Kista, Sweden.
- CEO
- Anders Weilandt
- IPO
- 2022
- Employees
- 3
- HQ
- Kista, SE
Price Chart
Valuation
- Market Cap
- $269.96K
- P/E
- -0.01
- P/S
- 0.30
- P/B
- 0.02
- EV/EBITDA
- 0.22
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 61.78%
- Op Margin
- -2189.89%
- Net Margin
- -2184.00%
- ROE
- -135.57%
- ROIC
- -140.49%
Growth & Income
- Revenue
- $664.69K · -31.92%
- Net Income
- $-27,253,583 · 6.62%
- EPS
- $-26.60 · 21.49%
- Op Income
- $-27,445,197
- FCF YoY
- 3.96%
Performance & Tape
- 52W High
- $16.00
- 52W Low
- $0.08
- 50D MA
- $0.65
- 200D MA
- $4.04
- Beta
- 1.51
- Avg Volume
- 153.16K
Get TickerSpark's AI analysis on CMH.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CMH.ST Coverage
We haven't published any research on CMH.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CMH.ST Report →